This announcement is a separate document:
海翔药业:海翔药业2023年年度股东大会见证法律意见书
Zhejiang Hisoar Pharmaceutical: Haixiang Pharmaceutical's 2023 Annual Shareholders' Meeting Witnessed Legal Opinions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.